Millennium Management’s Niagen Bioscience, Inc. Common Stock NAGE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$1.75M Sell
121,553
-479,347
-80% -$6.91M ﹤0.01% 2736
2025
Q1
$4.15M Buy
600,900
+374,811
+166% +$2.59M ﹤0.01% 2092
2024
Q4
$1.2M Buy
+226,089
New +$1.2M ﹤0.01% 2787
2024
Q3
Sell
-192,341
Closed -$525K 4571
2024
Q2
$525K Sell
192,341
-391,941
-67% -$1.07M ﹤0.01% 3182
2024
Q1
$2.03M Buy
584,282
+459,186
+367% +$1.6M ﹤0.01% 2576
2023
Q4
$179K Sell
125,096
-105,601
-46% -$151K ﹤0.01% 3593
2023
Q3
$337K Sell
230,697
-50,376
-18% -$73.5K ﹤0.01% 3420
2023
Q2
$441K Sell
281,073
-231,839
-45% -$364K ﹤0.01% 3342
2023
Q1
$785K Sell
512,912
-149,955
-23% -$230K ﹤0.01% 3199
2022
Q4
$1.11M Buy
662,867
+462,204
+230% +$777K ﹤0.01% 3082
2022
Q3
$247K Sell
200,663
-562,930
-74% -$693K ﹤0.01% 4315
2022
Q2
$1.28M Buy
+763,593
New +$1.28M ﹤0.01% 3248
2022
Q1
Sell
-225,920
Closed -$845K 5761
2021
Q4
$845K Buy
225,920
+72,852
+48% +$272K ﹤0.01% 3607
2021
Q3
$960K Buy
153,068
+50,850
+50% +$319K ﹤0.01% 3693
2021
Q2
$1.01M Sell
102,218
-806,695
-89% -$7.96M ﹤0.01% 3716
2021
Q1
$8.49M Buy
908,913
+812,958
+847% +$7.59M 0.01% 1547
2020
Q4
$461K Sell
95,955
-107,091
-53% -$515K ﹤0.01% 3286
2020
Q3
$814 Buy
203,046
+103,997
+105% +$417 ﹤0.01% 2597
2020
Q2
$455K Buy
+99,049
New +$455K ﹤0.01% 2781
2019
Q4
Sell
-154,733
Closed -$608K 3849
2019
Q3
$608K Buy
154,733
+133,985
+646% +$526K ﹤0.01% 2578
2019
Q2
$96K Buy
+20,748
New +$96K ﹤0.01% 3345
2018
Q2
Sell
-504,525
Closed -$2.12M 3816
2018
Q1
$2.12M Sell
504,525
-38,469
-7% -$162K ﹤0.01% 2115
2017
Q4
$3.19M Buy
542,994
+205,852
+61% +$1.21M ﹤0.01% 1860
2017
Q3
$1.45M Sell
337,142
-22,403
-6% -$96.4K ﹤0.01% 2132
2017
Q2
$1.37M Buy
359,545
+204,010
+131% +$779K ﹤0.01% 2082
2017
Q1
$418K Sell
155,535
-73,547
-32% -$198K ﹤0.01% 2673
2016
Q4
$758K Buy
+229,082
New +$758K ﹤0.01% 2216